GO
Loading...

Pharma Winners and Losers

Wednesday, 22 Aug 2012 | 3:15 AM ET

Gbola Amusa, head of European Pharmaceuticals research at UBS, told CNBC, earnings uncertainty around the loss of big drugs is coming to an end which will lead to a powerful re-rating for the sector.